OSIRIS THERAPEUTICS INC NEW - COM (OSIR)

CUSIP: 68827R108

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
10,114,363
Share change
+814,272
Total reported value
$186,496,872
Put/Call ratio
1340%
Price per share
$18.47
Number of holders
90
Value change
+$14,315,470
Number of buys
46
Number of sells
43

Quarterly Holders Quick Answers

What is CUSIP 68827R108?
CUSIP 68827R108 identifies OSIR - OSIRIS THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OSIRIS THERAPEUTICS INC NEW - COM (OSIR) as of Q3 2015

As of 30 Sep 2015, OSIRIS THERAPEUTICS INC NEW - COM (OSIR) was held by 90 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,114,363 shares. The largest 10 holders included FMR LLC, Consonance Capital Management LP, BlackRock Fund Advisors, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BAKER BROS. ADVISORS LP, STATE STREET CORP, NORTHERN TRUST CORP, Hood River Capital Management LLC, and SCHWAB CHARLES INVESTMENT MANAGEMENT INC. This page lists 90 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.